During the past decade, Windsor Regional Cancer Centre conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 24 clinical trials were completed, i.e. on average, 126.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 12 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Windsor Regional Cancer Centre" #1 sponsor was "NCIC Clinical Trials Group" with 23 trials, followed by "Ontario Clinical Oncology Group (OCOG)" with 12 trials sponsored, "Canadian Cancer Trials Group" with 8 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Windsor Regional Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "Eastern Cooperative Oncology Group" with 5 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Windsor Regional Cancer Centre" are "Breast Cancer" (22 trials), "Lung Cancer" (7 trials), "Prostate Cancer" (7 trials), "Colorectal Cancer" (4 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Windsor Regional Cancer Centre" in a lesser frequency.

Most popular intervention types in "Windsor Regional Cancer Centre" are "Drug" (58 trials), "Radiation" (17 trials), "Biological" (12 trials), "Other" (12 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "cisplatin" (5 trials), "paclitaxel" (5 trials), "prednisone" (5 trials) and "radiation therapy" (5 trials). Other intervention names were less common.

The vast majority of trials in "Windsor Regional Cancer Centre" are 45 trials for "All" genders, 26 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Windsor Regional Cancer Centre". 1 are not yet recruiting, 2 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Windsor Regional Cancer Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Windsor Regional Cancer Centre, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".